Skip to main content
Banana Farmer logo
Banana Farmer
System Transmission

_

Top Signal
100#1 JOB
Activity
2168Ripe
+909 today
System
Livenow
Terminal Asset View
stockNASDAQ

SER

$1.55-0.64%

AgeX Therapeutics Inc

Neutral
Official Site
Market value
24H Total Traded
Total supply
52-Week Range
Ripeness Index
Live Analysis Active

Company Mission

AgeX Therapeutics develops stem cell-based therapies designed to treat diseases related to aging, such as cardiovascular conditions and degenerative disorders. The company works with research institutions and pharmaceutical partners to advance its treatments through clinical trials. It generates revenue by licensing its technology to other companies and forming research collaborations, rather than selling products directly to consumers.

SER

Industry Context

AgeX operates in the biotechnology sector, specifically focusing on regenerative medicine. This industry develops treatments using biological processes to repair or replace damaged cells and tissues. Companies in this space often face long development timelines and significant regulatory hurdles before their therapies can reach patients.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified
Asset Diagnostics

Technical Matrix

Scanning
56Matrix
Market Momentum
37.2Oversold / Recovery
Trend Strength
25Active Setup

Momentum Engine

Ready
50
Velocity Score
StaticOptimal FlowMax Vel
Trading Activity
0.4xNormal Volume
Today's Change
-0.64%Live Performance

Social Frequency

Listening
4
Social Freq
0.1x
Normal Vol
X/Twitter Activity
0.1xStreaming
Reddit Buzz
0.0xSynced
System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

© 2026 Precision Engine
4Velocity
Live Sync

Social Intelligence Pulse.

Our engine is currently indexing SER across global social channels to detect early sentiment shifts and technical alignment.

XActive
RedditActive
WebActive

Signal Catalysts

Intelligence Narrative Connected

Updated 07:29 AM UTC
As-of 03-15-2026 07:13 UTC
Develops stem cell therapies to treat aging-related diseases and makes money by licensing its technology to other biotech companies.
Price below key moving averages, suggesting a downtrend as sellers have controlled recent price action showing consolidation pattern.
Biotech sector faces funding challenges as interest rates remain high, creating headwinds for early-stage research companies, suggesting research.

Educational only. Not investment advice.

Precision Intelligence Model
Live Terminal Stream

Loading chart...

Loading chart...

Loading chart...

Loading chart...